يعرض 1 - 10 نتائج من 16 نتيجة بحث عن '"Permanent atrial fibrillation"', وقت الاستعلام: 0.81s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    المساهمون: European Soc Cardiology, Ziekenhuis Oost-Limburg (ZOL), Fondazione Cardiocentro Ticino, University of Leeds, Imperial College London, Royal Brompton Hospital, Leiden University Medical Center (LUMC), University of Bergen (UiB), Karolinska Institutet [Stockholm], Cardiovascular Research Institute Maastricht (CARIM), Maastricht University [Maastricht], Aston University [Birmingham], Hannover Medical School [Hannover] (MHH), Karolinska University Hospital [Stockholm], Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Università degli Studi di Modena e Reggio Emilia, Julius Center for Health Sciences and Primary Care, University Medical Center [Utrecht], Tokuda Hospital Sofia, University of Wales, Silesian Medical University, Katowice, Poland, Aarhus University Hospital, University hospital of Zurich [Zurich], Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), University of Belgrade [Belgrade], Oslo University Hospital [Oslo], Antwerp University Hospital [Edegem] (UZA), University of Antwerp (UA), University of Zurich, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), RS: Carim - H01 Clinical atrial fibrillation, RS: Carim - H06 Electro mechanics, Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia (UNIMORE), Jonchère, Laurent, Universiteit Leiden, Cowie, Martin R/0000-0001-7457-2552, Nielsen, Jens, Cosedis/0000-0001-9414-1653

    المصدر: Europace, 23, 1324-1342
    Europace
    European Journal of Heart Failure
    European Journal of Heart Failure, Oxford University Press (OUP), 2020, 22 (12), pp.2349-2369. ⟨10.1002/ejhf.2046⟩
    EP Europace, 23(8), 1324-1342. Oxford University Press
    Europace, 23, 8, pp. 1324-1342
    Mullens, W, Auricchio, A, Martens, P, Witte, K, Cowie, M R, Delgado, V, Dickstein, K, Linde, C, Vernooy, K, Leyva, F, Bauersachs, J, Israel, C W, Lund, L, Donal, E, Boriani, G, Jaarsma, T, Berruezo, A, Traykov, V, Yousef, Z, Kalarus, Z, Nielsen, J C, Steffel, J, Vardas, P, Coats, A, Seferovic, P, Edvardsen, T, Heidbuchel, H, Ruschitzka, F & Leclercq, C 2020, ' Optimized Implementation of cardiac resynchronization therapy-a call for action for referral and optimization of care ', European Journal of Heart Failure, vol. 22, no. 12, pp. 2349-2369 . https://doi.org/10.1002/ejhf.2046Test
    European Journal of Heart Failure, 2021, 22 (12), pp.2349-2369. ⟨10.1002/ejhf.2046⟩

    مصطلحات موضوعية: genetic structures, medicine.medical_treatment, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], Cardiac resynchronization therapy, Care pathways, Disease Modification, Disease management, Heart failure, Implementation, Outcome, Response, Utilization, 030204 cardiovascular system & hematology, 0302 clinical medicine, LONG-TERM OUTCOMES, Medicine, Cardiac and Cardiovascular Systems, 030212 general & internal medicine, Disease management (health), Referral and Consultation, Ejection fraction, Kardiologi, ANGIOTENSIN-NEPRILYSIN INHIBITION, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, NONSUSTAINED VENTRICULAR-TACHYCARDIA, Treatment Outcome, Disease modification, 10209 Clinic for Cardiology, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Cardiology and Cardiovascular Medicine, BUNDLE-BRANCH BLOCK, medicine.medical_specialty, Referral, IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR, 610 Medicine & health, 11171 Cardiocentro Ticino, 03 medical and health sciences, Quality of life (healthcare), [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Physiology (medical), Humans, Treatment effect, PERMANENT ATRIAL-FIBRILLATION, Cardiac Resynchronization Therapy Devices, ATRIOVENTRICULAR JUNCTION ABLATION, Intensive care medicine, EXPERT CONSENSUS STATEMENT, [SDV.IB] Life Sciences [q-bio]/Bioengineering, HEART-FAILURE PATIENTS, business.industry, medicine.disease, Quality of Life, Human medicine, business, REDUCED EJECTION FRACTION

    وصف الملف: application/pdf; European_J_of_Heart_Fail_-_2020_-_Mullens_-_Optimized_implementation_of_cardiac_resynchronization_therapy_a_call_for.pdf - application/pdf; Mullens.pdf - application/pdf

  10. 10